SciELO - Scientific Electronic Library Online

 
vol.23 número3Establecimiento de un ensayo de potencia in vivo para el antígeno de superficie recombinante del virus de la Hepatitis B, en vacunas monovalentes y combinadasBiomodelos para la evaluación de cepas atenuadas como candidatos vacunales contra el cólera humano: Estudio de la toxigenicidad, inmunogenicidad y protección índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Vaccimonitor

versión impresa ISSN 1025-028X

Resumen

PANEQUE-SAYAS, Mayelin et al. Protection study of the Labio-Marek vaccine against the JM strain challenge in SPF chickens. Vaccimonitor [online]. 2014, vol.23, n.3, pp. 91-99. ISSN 1025-028X.

Marek's disease is a lymphomatous and neuropathic disease of the domestic chickens caused by herpesvirus. Currently the acute form of the disease, with extended visceral lymphomas, is the most common with an incidence of 10-30%. The objective of the present study was to evaluate the effectiveness of the vaccine Labio-Marek prepared by LABIOFAM against the challenge of the virulent JM strain in specific pathogen free chickens. A dose of the vaccine containing 1000 plate-forming units in 0.2 mL was inoculated in one-day old chickens by subcutaneous route. The chickens were challenged with 103 TCID50 of the JM strain and observed during 7 weeks to detect neurological signs such as paralysis and others associated with the disease. One group of chickens remained as a control of non-vaccinated chickens, which were challenged, and another group of chickens that was not vaccinated nor challenged. Autopsy was carried out at day 54 after vaccination on chickens that survived the challenge and histological evaluation of the organs was performed. The vaccinated chickens showed no clinical symptoms of the disease and had no microscopic lesions related to Marek's disease virus. However, 71% of non-vaccinated challenged chickens died and 83.87% showed lesions of Marek's disease. It is concluded that the evaluated vaccine can be used for the prevention of Marek's disease in chickens.

Palabras clave : Labio-Marek vaccine; Marek; vaccination.

        · resumen en Español     · texto en Español     · Español ( pdf )